Online citations, reference lists, and bibliographies.
← Back to Search

Upregulation Of CXCR4 Is Essential For HER2-mediated Tumor Metastasis.

Y. Li, Y. Pan, Y. Wei, X. Cheng, B. Zhou, M. Tan, X. Zhou, W. Xia, G. Hortobagyi, D. Yu, M. Hung
Published 2004 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
The receptor tyrosine kinase HER2 enhances tumor metastasis; however, its role in homing to metastatic organs is poorly understood. The chemokine receptor CXCR4 has recently been shown to mediate the movement of malignant cancer cells to specific organs. Here, we show that HER2 enhances the expression of CXCR4, which is required for HER2-mediated invasion in vitro and lung metastasis in vivo. HER2 also inhibits ligand-induced CXCR4 degradation. Finally, a significant correlation between HER2 and CXCR4 expression was observed in human breast tumor tissues, and CXCR4 expression correlated with a poor overall survival rate in patients with breast cancer. These results provide a plausible mechanism for HER2-mediated breast tumor metastasis and establish a functional link between HER2 and CXCR4 signaling pathways.
This paper references
10.1038/sj.onc.1203972
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
D. Yu (2000)
Serum inactivationthe G protein - coupled receptor CXCR 4 mediates lysosomal sorting
S. Villalba (2003)
10.1038/nature01874
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
P. Staller (2003)
Studies of the immunodeficiency disease
P. A. Hernandez (1989)
10.1074/jbc.274.13.8865
ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors*
R. Worthylake (1999)
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
M. Tan (1997)
10.1038/NM1197-1259
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
G. Scarlatti (1997)
10.1038/ncb1101-973
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
B. Zhou (2001)
10.3322/canjclin.49.1.8
Cancer statistics, 1999
S. Landis (1999)
10.1038/nri722
Chemokine receptors: multifaceted therapeutic targets
A. Proudfoot (2002)
10.1084/JEM.185.4.621
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
R. Connor (1997)
10.1146/ANNUREV.IMMUNOL.18.1.217
The biology of chemokines and their receptors.
D. Rossi (2000)
Hrs regulates endosome membrane invagination and tyrosine kinase p 34 ( Cdc 2 ) by ErbB 2 inhibits p 34 ( Cdc 2 ) activation and is involved in resistance to taxol - induced apoptosis
M. Tan (2002)
10.1189/jlb.0403149
Serum inactivation contributes to the failure of stromal‐derived factor‐1 to block HIV‐I infection in vivo
S. Villalba (2003)
10.1074/JBC.C100527200
Agonist-promoted Ubiquitination of the G Protein-coupled Receptor CXCR4 Mediates Lysosomal Sorting*
A. Marchese (2001)
10.1016/S1097-2765(02)00510-5
Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.
M. Tan (2002)
10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma
R. Camp (1999)
10.1101/GAD.887201
Regulation of translation initiation by FRAP/mTOR.
A. Gingras (2001)
10.1038/nature01338
A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor
Holger Knaut (2003)
10.1038/382635A0
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
T. Nagasawa (1996)
10.1186/bcr627
Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma
M. Kato (2003)
Expression chemotherapy plus a monoclonal antibody against HER 2 for metastatic pattern of CXC chemokine receptor - 4 is correlated with lymph node metasta - breast cancer that overexpresses HER 2
M. Kato (2003)
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
I. Zeelenberg (2003)
10.1038/35052073
Untangling the ErbB signalling network
Y. Yarden (2001)
10.1016/0169-5002(95)96312-j
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
D. Yu (1994)
10.1038/sj.onc.1202132
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs
R. Pietras (1998)
10.1038/nrc967
Metastasis suppressors alter the signal transduction of cancer cells
P. Steeg (2003)
Developmental biology : Germ - cell intestinal tract
R. Lehmann (2003)
10.1016/S0092-8674(02)00611-6
Hrs Regulates Endosome Membrane Invagination and Tyrosine Kinase Receptor Signaling in Drosophila
T. Lloyd (2002)
10.1016/S1535-6108(02)00122-8
Stable suppression of tumorigenicity by virus-mediated RNA interference.
T. Brummelkamp (2002)
Defects of is sufficient to induce experimental metastasis in 3 T 3 cells
M. C. Hung (1996)
10.1038/416451a
A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins
S. Polo (2002)
10.1016/S0006-3495(03)74696-7
HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.
B. Hendriks (2003)
10.1038/35065016
Involvement of chemokine receptors in breast cancer metastasis
A. Müller (2001)
10.1016/S0140-6736(72)92672-4
Treatment of breast cancer.
G. Edelstyn (1972)
10.1074/JBC.275.11.8027
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway*
B. Zhou (2000)
10.1126/SCIENCE.1063866
Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin
S. Shenoy (2001)
10.1016/S1535-6108(02)00154-X
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Jiong Deng (2002)
10.1002/cncr.11656
Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone
K. Klos (2003)
10.1056/NEJM200103153441101
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D. Slamon (2001)
The chemokine receptor CXCR 4 is required for outgrowth of colon carcinoma micrometas - lation
B. P. Zhou (2003)
10.1038/31269
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Y. Zou (1998)
Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis.
T. Yeatman (1993)
Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis.
Yeatman Tj (1993)
10.1038/425247a
Cancer: Cues for migration
R. Bernards (2003)
10.1038/421226a
Developmental biology: Germ-cell attraction
Prabhat S. Kunwar (2003)
10.1038/35065180
An attractive force in metastasis.
Liotta La (2001)
10.1126/SCIENCE.2470152
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
D. Slamon (1989)
10.1038/31261
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
K. Tachibana (1998)
human umbilical vein endothelial cells or simian virus - 40 transformated mu - Humanization of an anti - p 185 HER 2 antibody for human cancer therapy
L. Presta (1992)
10.1053/J.SEMINONCOL.2003.08.006
Dysregulation of cellular signaling by HER2/neu in breast cancer.
B. Zhou (2003)
10.1038/ng1149
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
Paolo A. Hernandez (2003)
Enhancement of Bik antitumor effect by Bik mutants.
Y. Li (2003)
10.1016/S1534-5807(03)00321-6
The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.
A. Marchese (2003)
10.1073/PNAS.89.22.10578
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
C. T. Guy (1992)
10.1126/SCIENCE.7112116
Biological diversity in metastatic neoplasms: origins and implications.
I. Fidler (1982)
Use of the stromal cell - derived factor - 1 / CXCR 4 path - tics , 1999
R. S. Taichman
10.1016/0092-8674(88)90184-5
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
W. Muller (1988)
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
R. Taichman (2002)
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells.
D. Yu (1991)
10.1073/PNAS.89.10.4285
Humanization of an anti-p185HER2 antibody for human cancer therapy.
P. Carter (1992)



This paper is referenced by
10.1002/ijc.21723
The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers
D. Palm (2006)
10.1016/j.cellsig.2012.11.024
Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling.
A. Marchese (2013)
The p 160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine / paracrine activity of SDF-1 a / CXCL 12
H. Kishimoto (2005)
10.1074/jbc.M116.758961
Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4
Jennifer C. Peeler (2017)
10.1227/NEU.0b013e318220a672
Cell Surface Receptors in Malignant Glioma
Y. Li (2011)
10.1053/j.gastro.2011.08.050
HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
W. Bao (2011)
10.1007/s10549-005-9121-8
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
O. Salvucci (2005)
10.1038/sj.bjc.6605020
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R. Marechal (2009)
10.4049/jimmunol.177.10.6983
CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma
O. Wald (2006)
10.2174/0929867324666170830111531
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
W. Zhou (2017)
10.25011/CIM.V32I3.6114
Co-expression of ER-beta and HER2 associated with poorer prognosis in primary breast cancer.
Wen-Sheng Qui (2009)
Étude sur les fonctions in vivo des GEFs DOCK chez les mammifères
M. Laurin (2014)
10.1016/j.semcancer.2013.12.007
The role of reactive oxygen species and metabolism on cancer cells and their microenvironment.
A. Costa (2014)
10.1007/s10585-007-9095-5
Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner
Thomas Dittmar (2007)
10.1507/ENDOCRJ.K08E-099
Estrogen-related cancer microenvironment of breast carcinoma.
Y. Yamaguchi (2009)
10.1186/1476-4598-10-107
Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
K. A. Manu (2010)
in Lung Adenocarcinoma CD4+CXCR4highCD69+ T Cells Accumulate
Amnon Peled (2013)
10.4314/TJPR.V13I8.18
Synthetic Polypeptide Derived from Viral Macrophage Inflammatory Protein II Inhibit VEGF Production of Human Glioma U87 Cells through SDF-1α/CXCR4-Mediated AKT Signaling Pathway
Bo Xu (2014)
10.4161/cc.4.6.1744
Wnt, Hedgehog, and Snail: Sister Pathways That Control by GSK-3beta and beta-Trcp in the Regulation of Metastasis
B. Zhou (2005)
10.1038/nrc1533
Metastasis: One step closer
N. McCarthy (2005)
10.1124/mol.107.039974
17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment
A. Pattarozzi (2008)
10.1155/2013/294320
Interleukin-19 in Breast Cancer
Ying-Yin Chen (2013)
Expression and Clinical Significance of EGFR , HER 2 and CXCR 4 in Non-small Cell Lung Cancer *
L. Li (2015)
10.1074/jbc.RA118.005991
Heterologous regulation of CXCR4 lysosomal trafficking
Adriana Caballero (2019)
10.1016/J.BBRC.2006.09.128
her-2 upstream open reading frame effects on the use of downstream initiation codons.
Christina C. Spevak (2006)
10.3389/fmicb.2020.00421
The Role of Chemokines in the Pathogenesis of HTLV-1
Razieh Zargari (2020)
10.1016/j.biocel.2017.12.018
The good and bad faces of the CXCR4 chemokine receptor.
J. Teixidó (2018)
10.1016/j.canlet.2013.10.006
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.
Polina Weitzenfeld (2014)
10.1007/978-1-4614-1960-0_20
CXCR4-Blockade for Treatment of Breast Cancer
P. Cronin (2012)
10.1093/CARCIN/BGL129
HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB
P. Maroni (2006)
10.1002/ijc.25076
Targeting endothelin A receptor enhances anti‐proliferative and anti‐invasive effects of the HER2 antibody trastuzumab in HER2‐overexpressing breast cancer cells
J. Fischgräbe (2010)
10.1158/0008-5472.CAN-06-3316
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
D. Palmieri (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar